Ensign PE ratio ENSG

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 27.5×
10-year median: 25.5×
Against its 10-year history: 65th; percentile: 0 is its lowest day, 100 its highest
10-year range: 15.9× to 39.2×
Peer median: 25.6×

Ensign's PE ratio is 27.5× as of Oct 23, 2026: a share price of $175.59 against $6.38 of earnings per share over the last twelve months.

That is above its ten-year median of 25.5×, higher than on 65% of days in the last ten years.

Over that time it ranged from 15.9× in Mar 2020 to 39.2× in Sep 2024.

The median for 10 hospital and care facility stocks of a similar size is 25.6×.

PE ratio over time

median 25.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	27.5×	24.3×	36.7×
2025	31.6×	24.5×	33.8×
2024	32.4×	26.3×	39.2×
2023	25.9×	21.5×	26.3×
2022	25.2×	21.4×	27.6×
2021	24.8×	21.7×	31.5×
2020	26.8×	15.9×	28.0×
2019	22.8×	21.1×	31.6×
2018	25.1×	23.4×	34.9×
2017	23.1×	16.9×	26.5×
2016	23.9×	16.4×	24.4×
2015	20.1×	19.4×	31.8×
2014	25.8×	9.7×	44.1×
2013	44.3×	6.6×	44.3×
2012	6.5×	5.7×	7.5×

Against its peers

Companies in Medical - Care Facilities nearest Ensign's size, closest first, today.

Company	PE ratio
ENSGEnsign	27.5×
UHSUniversal Health Services	7.6×
DVADavita	15.0×
BTSGBrightSpring Health Services	36.4×
EHCEncompass Health	20.2×
PACSPACS	27.2×
CHEChemed	25.8×
SHCSotera Health	31.8×
CONConcentra Group Holdings Parent	25.5×
LFSTLifeStance Health	99.5×
THCTenet Healthcare	10.4×
Peer median	25.6×

Where Ensign ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Ensign

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.